<DOC>
	<DOCNO>NCT00758498</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , parallel-group study armodafinil placebo treatment healthy subject excessive sleepiness associate jet lag disorder .</brief_summary>
	<brief_title>Study Effect Armodafinil Treatment Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disorders Excessive Somnolence</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Key History jet lag symptom past 5 year . The subject good health , determine medical psychiatric history , medical examination , clinical laboratory test result , electrocardiography ( ECG ) physical examination finding . Women childbearing potential must abstinent use medically accept method contraception , must continue use method duration study ( 30 day participation study ) . The subject willing comply study restriction remain study center overnight , require . The subject must agree refrain alcohol use study . The subject valid U.S. passport Key The subject history ( past 12 month ) diagnosis narcolepsy , obstructive sleep apnea/hypopnea syndrome ( OSAHS ) , shift work sleep disorder ( SWSD ) , sleep disorder associate excessive daytime sleepiness ; subject history current diagnosis hypersomnia , insomnia , sleep disorder . The subject serious acute chronic cardiovascular , pulmonary , gastrointestinal , neurological , endocrine renal illness ( include diabetes mellitus ) , hepatitis , asthma , chronic obstructive pulmonary disease ( COPD ) , clinically relevant significant medical condition . The subject history cutaneous drug reaction drug hypersensitivity , clinically significant hypersensitivity reaction , multiple allergy . The subject history deep vein thrombosis ( DVT ) . The subject know human immunodeficiency virus ( HIV ) . The subject pregnant lactating . The subject use nicotine within last 3 month . The subject history seizure , except single febrile seizure . The subject psychiatric disorder would affect participation study full compliance study procedure . The subject clinically significant deviation normal clinical laboratory result , vital sign measurement , physical examination finding . The subject use prescription counter drug disallow protocol within 7 day screen visit 2 ( i.e. , stimulant , hypnotic ) . The subject use investigational drug within 1 month screen visit . The subject disorder may interfere drug absorption , distribution , metabolism , excretion . The subject know hypersensitivity armodafinil modafinil , component study drug tablet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>